Imaging societies urge CMS to reconsider covering NaF PET exams

The World Molecular Imaging Society, American College of Radiology, Society of Nuclear Medicine and Molecular Imaging and members of the National Oncologic PET Registry (NOPR) Working Group issued a statement Friday, June 8, urging CMS to reconsider its decision to decline coverage for PET imaging with sodium fluoride (NaF) for Medicare patients with metastatic cancer.